Get alerts when NXPL reports next quarter
Set up alerts — freeNextPlat shares fell 15.3% after the earnings release, with the transcript pointing to ongoing pressure in retail pharmacy revenue and a sequential $0.3 million decline in medication-fulfillment contracts after a customer closed a facility. Management also delayed the healthcare e-commerce launch to this month, tempering the turnaround narrative despite year-over-year improvement in margins and operating losses.
See NXPL alongside your other holdings
Add to your portfolio — freeTrack NextPlat Corp Common Stock in your portfolio with real-time analytics, dividend tracking, and more.
View NXPL Analysis